SILINTAN 25/pills recall — Class I (D-0388-2026) · pharmaranks
Class IOngoing
SILINTAN 25/pills recall
FDA recall D-0388-2026 · initiated Oct 20, 2025
Most serious — a reasonable probability that use will cause serious harm or death.
Why it was recalled
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Details
Product
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Recalling company
ANTHONY TRINH, 123Herbals LLC
Classification
Class I
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
USA nationwide
Initiated
Oct 20, 2025
FDA report date
Mar 11, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.